Stay updated on Nivolumab & IRX-2 in Oral/HPV Cancer Surgery Clinical Trial
Sign up to get notified when there's something new on the Nivolumab & IRX-2 in Oral/HPV Cancer Surgery Clinical Trial page.

Latest updates to the Nivolumab & IRX-2 in Oral/HPV Cancer Surgery Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check26 days agoChange DetectedRemoved the government funding status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check49 days agoChange DetectedScreenshots show only minor UI/layout updates and duplicated sections, with no changes to core trial data such as status, enrollment, eligibility criteria, interventions, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check70 days agoChange Detected- Added a prominent operating-status notice and link guidance for NIH Clinical Center, and a new version tag v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference2%

- Check77 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page was updated to revision v3.0.2, replacing v3.0.1, and the 'Back to Top' link was removed.SummaryDifference0.1%

Stay in the know with updates to Nivolumab & IRX-2 in Oral/HPV Cancer Surgery Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab & IRX-2 in Oral/HPV Cancer Surgery Clinical Trial page.